Current Portfolio Companies

$40 million invested in eight companies.

Encore Vision

Ophthalmology company focused on a novel treatment in presbyopia

Lung Therapeutics, Inc.

Pulmonology company focused on Fibrosis

Cognition Therapeutics, Inc.

Neurosciences company focused on Alzheimer’s

Actuate Therapeutics, Inc.

Oncology company focused on drug and radiation resistance

Azitra, Inc.

Microbiome company focused on eczema and dermatology

410 Medical, Inc.

Medtech company focused on fluids and trauma

Abilitech Medical, Inc.

Medtech company focused on orphan diseases

Lantern Pharma, Inc.

Biotech company focused on precision medicine and oncology